Diabetic Ketoacidosis (DKA): Symptoms, Causes, Diagnosis & Treatment

Diabetic ketoacidosis is a catabolic cascade initiated when circulating insulin falls below the threshold needed to suppress adipose lipolysis and hepatic ketogenesis while counter-regulatory stress hormones remain active. Free fatty acids feed ketone body production (principally β-hydroxybutyrate), which overwhelms peripheral oxidation and generates high anion-gap metabolic acidosis. Osmotic diuresis from glycosuria exaggerates free water and electrolyte losses, so patients arrive intravascularly depleted despite sometimes misleading “normal” blood pressure readings in young adults.

Although classically framed in type 1 diabetes, the same physiology appears when type 2 diabetes becomes effectively insulin-deficient, during acute medical stress, or after sodium–glucose cotransporter-2 inhibition even when glucose is modest. Framing DKA as “ketonaemia + acidosis with inadequate insulin action” keeps the nurse alert to atypical presentations that bypass triage rules based on glucose alone.

Use local definitions; most adult pathways stratify by venous pH, bicarbonate, mental status, and haemodynamics rather than glucose alone. The table condenses common teaching divisions—always align documentation with your institution’s flow sheet.

↔On a small screen, swipe or scroll sideways to see the full table.

Classic presentation

Polydipsia and polyuria mirror hyperglycaemic osmotic diuresis; many people describe weight loss, fatigue, and progressive nausea with vomiting. Kussmaul (deep) respirations signal respiratory compensation for metabolic acidosis, and ketotic breath may be reported. Symptoms overlap hyperglycaemia patterns but progress faster when ketonaemia dominates.

Atypical or high-risk variants

• Euglycaemic DKA: prominent dehydration, vomiting, and acidosis with glucose that does not impress triage cut-offs—ketone testing closes the loop.
• Older adults: more confusion, subtle hypovolemia, and comorbid cardiovascular disease mask classic Kussmaul breathing.
• Pregnancy: higher ketone turnover; lower CO₂ buffering may steepen acidosis; involve obstetric and endocrine teams early.

DKA is rarely “idiopathic”—search for a second driver even after fluids start.

Precipitants (common)

• Infection or systemic inflammatory response—consider sepsis bundles if shock coexists.
• New-onset or established type 1 diabetes with interrupted insulin access.
• Pancreatic inflammation—abdominal pain warrants lipase/is enzyme pathway (clinical overview of pancreatitis).
• Insulin omission, pump failure, or sick-day mismanagement.
• Drug-associated ketosis—SGLT2 inhibitors, high-dose glucocorticoids, atypical antipsychotics, and alcohol misuse each alter risk in characteristic ways.

Risk amplifiers

• Adolescents and young adults with volatile insulin adherence.
• Pregnancy, perioperative stress, or critical illness requiring vasopressors.
• Renal impairment slowing ketone clearance (acute kidney injury physiology).

Clinical assessment

Measure work of breathing, perfusion, Glasgow score, pregnancy status, and potential infection sources. Correlate symptoms with medication lists—especially SGLT2 exposure in the preceding days—and confirm last basal insulin dose or pump integrity.

Laboratory investigations

• Venous blood gas (pH, bicarbonate, calculated anion gap) or arterial sampling if respiratory failure obscures ventilation status.
• Blood glucose paired with serum β-hydroxybutyrate or validated ketone assay; urinalysis ketones lag and may miss hydroxybutyrate dominance.
• Serum electrolytes with calculated anion gap; anticipate “normal” or high sodium despite severe dehydration due to dilution.
• Lactate if shock or sepsis is plausible—helps separate pure gap acidosis from combined disorders.
• Osmolality where mixed hyperosmolar physiology suspected.
• Directed cultures or imaging once stabilized enough for safe transport.

Imaging

No routine imaging defines DKA; use bedside ultrasound, chest radiograph, or CT only to answer a specific precipitant question (for example pneumonia, perforated viscus, or suspected pancreatitis).

Criteria used operationally

Operational diagnosis marries ketonaemia, metabolic acidosis with widened anion gap, and hyperglycaemia except in euglycaemic variants where ketones and acidosis remain obligatory. Admission and severity coding should mirror your hospital’s DKA order set and national audit definitions.

Gap acidosis in diabetes is not always ketotic; mixed pictures are common in critically ill adults.

↔On a small screen, swipe or scroll sideways to see the full table.

Management is protocol-driven: simultaneous resuscitation, insulin, electrolytes, and precipitant care.

First-line management

• Isotonic crystalloid boluses followed by scheduled replacement targeting clinical perfusion and lab trends—track intake and output rigorously.
• Continuous IV regular (soluble) insulin infusion via dedicated pump; use organisation-approved concentrations and double-check MAR against infusion device (pump setup checklist).
• Glucose fall often exceeds ketone clearance—add dextrose-containing fluids per protocol to keep glucose in the “safe descent” window without stopping insulin intended to suppress ketogenesis.
• Potassium replacement usually continuous once renal function and urine output permit; hold or adjust insulin per critical low thresholds.
• Identify and treat precipitant: antibiotics if sepsis suspected, symptom control for pancreatitis under specialist guidance, pump troubleshooting, psychosocial barriers to insulin access.

Second-line / rescue considerations

• Bicarbonate remains contentious—reserved for extreme acidosis with haemodynamic collapse per local policy.
• Vasopressors only after adequate fluid loading unless cardiogenic limits intervene.
• Airway protection when exhaustion or declining consciousness threaten ventilation.

Transition off infusion

Switch to subcutaneous basal-bolus only after ketonaemia resolves and the patient can eat; overlap infusion with first subcutaneous dose per protocol—often using a rapid-acting analogue such as the medication monograph for insulin lispro paired with scheduled basal insulin. Document education on pump or pen use and subcutaneous insulin administration technique before discharge.

Special populations

• Pregnancy: obstetric-led targets, fetal monitoring when viable, aggressive ketone surveillance.
• Renal impairment: slower fluid rates, cautious potassium replacement, closer neurology checks.
• Older adults: cardiac comorbidity may cap fluid rates—balance perfusion with overload risk.

• Monitoring cadence: early hourly blood glucose monitoring with paired ketone checks until institution-defined resolution; extend intervals only when consistent improvement holds.
• Potassium choreography: redraw electrolytes after boluses and before each infusion rate change when protocols dictate; never “borrow” insulin from the bag without pharmacy review.
• Iatrogenic hypoglycaemia: when glucose falls into range but ketones persist, add dextrose rather than halting insulin prematurely—watch for hypoglycaemia symptoms once shifting to subcutaneous coverage.
• Treatment delay triggers: rising lactate, refractory hypotension, falling Glasgow score, widening gap despite therapy—escalate to intensivist and reassess fluid, sepsis, and insulin delivery integrity.
• Documentation: time-stamp fluid boluses, insulin rate changes, verbal medical reviews, and patient education on SGLT2 sick-day rules.

Clinical decision flow (shift-ready)

1. Recognise vomiting + hyperglycaemia + ketosis pattern → activate DKA pathway and two large-bore lines.
2. Stabilise airway, obtain VBG, electrolytes, ketones, ECG if K⁺ unknown.
3. Resuscitate with balanced fluid plan; correct K⁺ before insulin if below protocol threshold.
4. Deliver fixed-rate insulin; adjust glucose descent with dextrose additives, not ad hoc insulin stops.
5. Hunt infection, pump failure, pancreatitis, or pregnancy—order targeted tests once safe.
6. Step-down to subcutaneous insulin only after biochemical resolution and meal tolerance.

Bedside monitoring checklist

• Heart rate, blood pressure, respiratory rate, SpO₂, temperature, urine output.
• Neurologic checks each shift—any headache with hypertension in a child signals emergency review.
• Infusion line integrity; duplicate pump programming verification when handing over care.

• Hypokalaemia and arrhythmia during insulin-mediated intracellular shift.
• Acute kidney injury from sustained hypoperfusion or contrast exposure during precipitant workup.
• Pulmonary oedema if fluids outpace cardiac reserve—especially in older adults.
• Cerebral oedema (predominantly paediatric) presenting with headache, bradycardia with hypertension, seizures, or rapid GCS fall.
• Hypoglycaemia at transition if basal insulin is delayed relative to infusion cessation.
• Thromboembolism risk elevation during recovery—mobilization and prophylaxis per local VTE policy.

Clinician-facing prevention centers on uninterrupted basal insulin during illness, structured sick-day rules, ketone testing when glucose rises or vomiting begins, and proactive insulin dose help lines. For SGLT2 inhibitor therapy, align inpatient hold policies and perioperative guidance with endocrinology and anaesthesia. Discharge teaching should reference long-term type 1 specialist follow-up and community supply contingencies so gaps in insulin availability do not repeat.

Mortality is now uncommon in previously healthy adults when protocols start early, but case-fatality rises with extreme acidosis, delayed antibiotics in sepsis, and limited critical-care access. Functional recovery is typical when precipitants resolve; recurrent admissions flag psychosocial barriers, insulin insecurity, or undiagnosed endocrine overlap.

Communication and safety

Use plain language when explaining why ketone testing continues after glucose improves; many patients fear “being overdosed” with glucose plus insulin simultaneously. Reassure that the infusion aims to clear ketones, not only the number on the glucometer.

Medication safety

Insulin infusions demand line secrecy—no piggybacking incompatible drugs. Trace every bag and rate change in two-person verification where policy requires it. Never abbreviate “units” on handwritten bridges if paper persists.

Escalation cues

• Rising potassium despite oliguria—nephrology and critical-care notification.
• Any seizure or sudden behaviour change during correction—activate emergency paediatric or neuroprotective pathways.
• Persistent vomiting preventing oral fluids at transition—surgical or medical review before stopping IV therapy.

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and a compact cloze on the topic of DKA recognition (hyperglycaemia + ketonaemia + acidosis), structured fluid + fixed-rate insulin + electrolyte bundle and the hypokalaemia / hypoglycaemia / cerebral-oedema / euglycaemic-DKA red flags.